
brief_title:  Ranolazine Cardioprotection in PCI
official_title: Ranolazine Cardioprotection in PCI
brief_summary:
 The investigators will test if upfront dosing of Ranolazine can reduce myocardial biomarker release (CK-MB, Troponin) post percutaneous coronary intervention (PCI).
inclusion_criteria:
 - Age 18 or older - Patients undergoing Coronary Angiography with possible PCI - Able and willing to give consent - Able to read and write English
exclusion_criteria:
 - Current EKG or Biomarker of Acute Myocardial Infarction (MI) or Acute Coronary Syndromes (ACS) Sense6 - History of Allergy to Ranolazine - Pregnant or Nursing - Currently taking Ranolazine
